Webcast and Conference Call Information
The Company will hold a teleconference call and live webcast today at 10:00 a.m. Eastern Time to discuss the results followed by a question and answer session hosted by Mr. Anderson.
To listen to the live teleconference, please dial 201-689-8261 a few minutes prior to 10:00 a.m. A replay of the teleconference will be available October 30 through November 6 and can be accessed by calling 877-660-6853 (toll free) or 201-612-7415. The account number for the replay is 244 and the conference number is 299502.
The live webcast and replay can be accessed by going to the Investor Relations section of the CryoLife Web site at http://www.cryolife.com and selecting the heading Webcasts & Presentations.
About CryoLife, Inc.
Founded in 1984, CryoLife, Inc. is a leader in the processing and
distribution of implantable living human tissues for use in cardiac and
vascular surgeries throughout the U.S. and Canada. The Company recently
received FDA clearance for the CryoValve(R) SG pulmonary human heart valve,
processed using CryoLife's proprietary SynerGraft(R) Technology. The
Company's BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to
sutures and staples for use in adult patients in open surgical repair of
large vessels. BioGlue is also CE marked in the European Community and
approved in Canada and Australia for use in soft tissue repair. CryoLife
distributes Hemostase MPH(R), a hemostatic agent, in much of the U.S. for
use in cardiac and vascular surgery and in the United Kingdom, Germany,
France, and Canada for cardiac, vascular, and general surgery, subject to
certain exclusions. The Company also distributes the CryoLife-O'Brien(R)
Stentless Porcine Aortic Bioprost
|SOURCE CryoLife, Inc.|
Copyright©2008 PR Newswire.
All rights reserved